Search Details

Word: tb (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Edwards, the McKay professor of the practice of biomedical engineering, has developed an innovative technique for vaccinating patients against TB. His approach administers the vaccine through an inhaled spray, rather than the typical needle...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: A New Deal On Lifesaving Drugs | 11/13/2006 | See Source »

Typically, Harvard licenses its faculty’s cutting-edge discoveries to for-profit companies, earning royalties in return. But this time, Harvard is taking the unusual step of forgoing much of its royalties on Edwards’ TB vaccine spray both in the U.S. and abroad...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: A New Deal On Lifesaving Drugs | 11/13/2006 | See Source »

...problems with the current BCG method. It doesn’t require needles—thus eliminating the HIV risk—and may also prove more effective than injecting needles under the skin. The spray immunizes directly through the lungs, which is the route of infection for TB. The new method may also depend less on refrigeration...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: A New Deal On Lifesaving Drugs | 11/13/2006 | See Source »

...sales of Edwards’ TB spray, the University will forgo all of the royalties it earns in developing countries, and a major share of its royalties in developed countries, as well. Harvard will divert those earnings back to MEND, says Isaac Kohlberg, who leads the University’s licensing office...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: A New Deal On Lifesaving Drugs | 11/13/2006 | See Source »

...such firms are wary of committing resources to markets that hold little promise of a return on their investment. And with most TB victims living in Africa and Southeast Asia, Edwards’ spray is far less lucrative than drugs that target ailments such as high cholesterol and heart disease that are common in industrialized nations...

Author: By Nicholas M. Ciarelli and Daniel J. T. Schuker, CRIMSON STAFF WRITERSS | Title: A New Deal On Lifesaving Drugs | 11/13/2006 | See Source »

Previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Next